Vasilii Tkachenko
Research Subjects
Research Interests
Vasilii Tkachenko has a total of 27 co-authors. Here are the top co-authors by number of shared publications:
- Elena A. Korabelnikova
I.M. Sechenov First Moscow State Medical University (Sechenov University)
6 shared publications - Alena Petrovna Sidenkova
Ural State Medical University
1 shared publication - Alexey B. Danilov
Department for Nervous Diseases, I.M. Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation (Sechenov University), Moscow, Russia
1 shared publication - Anastasiia Badaeva
Department for Pathological Physiology, I.M. Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation , Moscow , Russia
1 shared publication - Anastasiia V Petrokovskaia
Loginov Moscow Clinical Scientific Center
1 shared publication - Anastasiia Vitish
Department for Nervous Diseases, I.M. Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation , Moscow , Russia
1 shared publication
Latest Publications
- 15 April 2026
- Published by Media Sphere Publishing Group in S.S. Korsakov Journal of Neurology and Psychiatry
- Vol. 126 (3) , 68-73
Frequency of 5q spinal muscular atrophy in adults with unspecified neuromuscular diseases
Objective. To assess the prevalence of 5q spinal muscular atrophy (SMA) among adult patients with undifferentiated neuromuscular disorders. Material and methods. Prospective study of 50 patients (19—78 years) presenting ≥1 feature of 5q SMA: areflexia, proximal weakness, fasciculations, neurogenic EMG changes, atrophy, calf hypertrophy, or elevated creatine kinase (CK). Molecular testing (MLPA/melting curve analysis of SMN1/SMN2) was performed. Results. 5q SMA was confirmed in one female patient (2% [95% CI 0.05—10.6]), who was found to have a homozygous deletion of exons 7—8 in the SMN1 gene. Her clinical presentation included proximal lower limb weakness and neurogenic EMG changes, but she lacked areflexia and had normal CK levels. For 29 years, she had been misdiagnosed with «unspecified myopathy»(G72.9). Conclusion. The findings highlight the need to include 5q SMA in the differential diagnosis of adult patients with undifferentiated neuromuscular disorders. Optimizing diagnostic algorithms and enhancing epidemiological monitoring in this age group are essential to reduce diagnostic delays.
- 15 April 2026
- Published by Media Sphere Publishing Group in S.S. Korsakov Journal of Neurology and Psychiatry
- Vol. 126 (3) , 68-73
Frequency of 5q spinal muscular atrophy in adults with unspecified neuromuscular diseases
Objective. To assess the prevalence of 5q spinal muscular atrophy (SMA) among adult patients with undifferentiated neuromuscular disorders. Material and methods. Prospective study of 50 patients (19—78 years) presenting ≥1 feature of 5q SMA: areflexia, proximal weakness, fasciculations, neurogenic EMG changes, atrophy, calf hypertrophy, or elevated creatine kinase (CK). Molecular testing (MLPA/melting curve analysis of SMN1/SMN2) was performed. Results. 5q SMA was confirmed in one female patient (2% [95% CI 0.05—10.6]), who was found to have a homozygous deletion of exons 7—8 in the SMN1 gene. Her clinical presentation included proximal lower limb weakness and neurogenic EMG changes, but she lacked areflexia and had normal CK levels. For 29 years, she had been misdiagnosed with «unspecified myopathy»(G72.9). Conclusion. The findings highlight the need to include 5q SMA in the differential diagnosis of adult patients with undifferentiated neuromuscular disorders. Optimizing diagnostic algorithms and enhancing epidemiological monitoring in this age group are essential to reduce diagnostic delays.
- Open Access
- 1 January 2026
- Published by Walter de Gruyter GmbH in Open Medicine
- Vol. 21 (1)
Characterizing insomnia and sleep quality in a cohort with tension type headache
Objectives: Emerging literature data indicate insomnia as an risk factor for headache or migraine onset. It is generally recognized that headache and insomnia represent very common and major complaints worldwide, while finding exisit that indicate a symmetrical association, with headache being more associated with insomnia than the other way around. Therefore, in the association of headache and insomnia, other factors associated with headache or migraine probably play a role, as well. The aim of the study was to evaluate the clinical and pathogenetic relationships between insomnia and chronic tension-type headache (CTTH). Methods: A prospective cohort study included 65 patients with CTTH and comorbid chronic insomnia. Participants underwent clinical evaluation, assessment of headache severity (VAS, HIT-6), insomnia (PSQI, ISI), emotional state (Beck, Sheehan scales), and quality of life (SF-12). A subset (n=17) underwent polysomnography (PSG). Results: All patients reported poor sleep quality. A significant discrepancy was found between subjective sleep perception and objective PSG data (p<0.001). Patients with more severe insomnia had significantly higher levels of anxiety (p<0.001), depression (p=0.025), central sensitization (p<0.001), and lower quality of life (p<0.002). Correlation analysis revealed that worse sleep parameters (e.g., reduced REM, increased wakefulness) were associated with higher headache impact, emotional distress, and central sensitization, particularly in the mild insomnia group. Conclusions: Insomnia in CTTH patients exacerbates the condition not primarily by intensifying pain itself, but by amplifying its negative impact on emotional state and quality of life, and by strengthening the interconnections between various clinical and psychophysiological manifestations. Treating insomnia is crucial for improving overall patient well-being and pain tolerance.
- 1 January 2026
- Published by Walter de Gruyter GmbH in Open Medicine
- Vol. 21 (1)
Open AccessCharacterizing insomnia and sleep quality in a cohort with tension type headache
Objectives: Emerging literature data indicate insomnia as an risk factor for headache or migraine onset. It is generally recognized that headache and insomnia represent very common and major complaints worldwide, while finding exisit that indicate a symmetrical association, with headache being more associated with insomnia than the other way around. Therefore, in the association of headache and insomnia, other factors associated with headache or migraine probably play a role, as well. The aim of the study was to evaluate the clinical and pathogenetic relationships between insomnia and chronic tension-type headache (CTTH). Methods: A prospective cohort study included 65 patients with CTTH and comorbid chronic insomnia. Participants underwent clinical evaluation, assessment of headache severity (VAS, HIT-6), insomnia (PSQI, ISI), emotional state (Beck, Sheehan scales), and quality of life (SF-12). A subset (n=17) underwent polysomnography (PSG). Results: All patients reported poor sleep quality. A significant discrepancy was found between subjective sleep perception and objective PSG data (p<0.001). Patients with more severe insomnia had significantly higher levels of anxiety (p<0.001), depression (p=0.025), central sensitization (p<0.001), and lower quality of life (p<0.002). Correlation analysis revealed that worse sleep parameters (e.g., reduced REM, increased wakefulness) were associated with higher headache impact, emotional distress, and central sensitization, particularly in the mild insomnia group. Conclusions: Insomnia in CTTH patients exacerbates the condition not primarily by intensifying pain itself, but by amplifying its negative impact on emotional state and quality of life, and by strengthening the interconnections between various clinical and psychophysiological manifestations. Treating insomnia is crucial for improving overall patient well-being and pain tolerance.
- 1 November 2025
- Published by Springer Nature in Neuroscience and Behavioral Physiology
- Vol. 55 (9) , 1674-1680
Effects of Insomnia Therapy on Treatment Outcomes in Patients with Chronic Tension Headache
- 1 November 2025
- Published by Springer Nature in Neuroscience and Behavioral Physiology
- Vol. 55 (9) , 1674-1680
Effects of Insomnia Therapy on Treatment Outcomes in Patients with Chronic Tension Headache
- 27 June 2025
- Published by Media Sphere Publishing Group in S.S. Korsakov Journal of Neurology and Psychiatry
- Vol. 125 (6) , 77-83
The effect of insomnia therapy on treatment outcomes in patients with chronic tension headache
The purpose of the study: to assess objective and subjective sleep indicators in patients with chronic tension headache and their change during therapy. Material and methods. The study included 65 patients with chronic tension headache and insomnia. The assessment was conducted using headache questionnaires (headache VAS, headache diary, HIT-6, pain catastrophization scale), sleep quality questionnaires (Pittsburgh Sleep Quality Index (PSQI), sleep quality VAS), psychometric testing (Beck Depression Scale, Sheehan Anxiety Scale), a central sensitization questionnaire, and polysomnography. Patients were divided into two groups: patients of group 1 received prophylactic treatment with a drug for relief of insomnia symptoms and recommendations for sleep hygiene according to clinical guidelines, and patients of group 2 received only a drug for prophylactic treatment of headache. Results. In the group with insomnia treatment, the duration of the S3 phase of slow-wave sleep increased from 31.5 (27;36) to 47 (42;49) minutes and the subjective duration of sleep from 360±90 to 453.33±66.14 minutes, the severity of insomnia PSQI score decreased from 13 (10;15) to 7 (5;10) points, the frequency of headache reduced from 20.00 [17.00; 24.00] to 8.00 [5.00; 11.00] days and the pain intensity VAS decreased from 7.00 [6.00; 7.00] to 4.00 [3.00; 6.00] points, the anxiety severity according to the Sheehan Anxiety Scale decreased from 43 [26;51] to 19 [16;34 ] points and depression severity according to the Beck Depression Scale reduced from 14 [12;18] to 7 [6;10.5] points. Conclusion. Diagnosis and treatment of insomnia in patients with chronic tension headaches is an important strategy in managing this group of patients. This strategy allows not only to improve the objective and subjective sleep parameters but also to reduce the headache and the severity of comorbidities.
- 27 June 2025
- Published by Media Sphere Publishing Group in S.S. Korsakov Journal of Neurology and Psychiatry
- Vol. 125 (6) , 77-83
The effect of insomnia therapy on treatment outcomes in patients with chronic tension headache
The purpose of the study: to assess objective and subjective sleep indicators in patients with chronic tension headache and their change during therapy. Material and methods. The study included 65 patients with chronic tension headache and insomnia. The assessment was conducted using headache questionnaires (headache VAS, headache diary, HIT-6, pain catastrophization scale), sleep quality questionnaires (Pittsburgh Sleep Quality Index (PSQI), sleep quality VAS), psychometric testing (Beck Depression Scale, Sheehan Anxiety Scale), a central sensitization questionnaire, and polysomnography. Patients were divided into two groups: patients of group 1 received prophylactic treatment with a drug for relief of insomnia symptoms and recommendations for sleep hygiene according to clinical guidelines, and patients of group 2 received only a drug for prophylactic treatment of headache. Results. In the group with insomnia treatment, the duration of the S3 phase of slow-wave sleep increased from 31.5 (27;36) to 47 (42;49) minutes and the subjective duration of sleep from 360±90 to 453.33±66.14 minutes, the severity of insomnia PSQI score decreased from 13 (10;15) to 7 (5;10) points, the frequency of headache reduced from 20.00 [17.00; 24.00] to 8.00 [5.00; 11.00] days and the pain intensity VAS decreased from 7.00 [6.00; 7.00] to 4.00 [3.00; 6.00] points, the anxiety severity according to the Sheehan Anxiety Scale decreased from 43 [26;51] to 19 [16;34 ] points and depression severity according to the Beck Depression Scale reduced from 14 [12;18] to 7 [6;10.5] points. Conclusion. Diagnosis and treatment of insomnia in patients with chronic tension headaches is an important strategy in managing this group of patients. This strategy allows not only to improve the objective and subjective sleep parameters but also to reduce the headache and the severity of comorbidities.
- 23 April 2024
- Published by Media Sphere Publishing Group in S.S. Korsakov Journal of Neurology and Psychiatry
- Vol. 124 (5) , 105-109
The clinical significance of insomnia in chronic headache
OBJECTIVE To study the features of the manifestation of insomnia and its impact on the condition and quality of life in patients with chronic tension-type headache. MATERIAL AND METHODS The study included 65 patients with chronic tension-type headache and insomnia. Patients filled out questionnaires on headache severity, sleep quality, emotional status and quality of life. Seventeen patients underwent polysomnography. RESULTS Patients with more severe insomnia had significantly more severe anxiety (pp=0.025). Such patients assessed their quality of life worse according to the SF-12 questionnaire (ppp<0.001). CONCLUSION The negative impact of insomnia on the condition of patients is not so much an increase in pain as such, but rather its influence on the quality of the emotional state and life in general, as well as an increase in the interdependence and mutual influence of other clinical and psychophysiological manifestations of the disease. Therefore, the clinical significance of insomnia is the deterioration of a person’s ability to tolerate pain, which is the main prerequisite for a decrease in quality of life.
- 23 April 2024
- Published by Media Sphere Publishing Group in S.S. Korsakov Journal of Neurology and Psychiatry
- Vol. 124 (5) , 105-109
The clinical significance of insomnia in chronic headache
OBJECTIVE To study the features of the manifestation of insomnia and its impact on the condition and quality of life in patients with chronic tension-type headache. MATERIAL AND METHODS The study included 65 patients with chronic tension-type headache and insomnia. Patients filled out questionnaires on headache severity, sleep quality, emotional status and quality of life. Seventeen patients underwent polysomnography. RESULTS Patients with more severe insomnia had significantly more severe anxiety (pp=0.025). Such patients assessed their quality of life worse according to the SF-12 questionnaire (ppp<0.001). CONCLUSION The negative impact of insomnia on the condition of patients is not so much an increase in pain as such, but rather its influence on the quality of the emotional state and life in general, as well as an increase in the interdependence and mutual influence of other clinical and psychophysiological manifestations of the disease. Therefore, the clinical significance of insomnia is the deterioration of a person’s ability to tolerate pain, which is the main prerequisite for a decrease in quality of life.
- Open Access
- 23 November 2023
- Published by Remedium, Ltd. in Meditsinskiy sovet = Medical Council
- No. 21,p. 64-69
The effect of insomnia correction on the duration and severity of headaches
Introduction. Chronic tension headache and insomnia are a common mutually aggravating pathology. Drugs used to treat these nosologies most often worsen the course of the concomitant disease.Objective. To evaluate the effect of insomnia correction on the intensity and frequency of headachesMaterials and methods. The study involved 27 patients (25 women, 2 men) with chronic tension-type headache and sleep disorders. The median age was 43 ± 14.8 years. In accordance with the purpose of the study, the clinical group was divided into 2 subgroups. The first group was treated with venlafaxine and doxylamine, the patients of the second group received only venlafaxine treatment. The assessment was carried out before the start of treatment and 8 weeks after, using visual analogue scales for headache, sleep, health status, assessing the severity of insomnia using the Morin scale and the Pittsburgh Sleep Quality Inventory (PSQI), assessing the emotional state using the Sheehan anxiety and Beck depression scales and polysomnography.Results. In subgroup 1, which received correction of insomnia, there was a significant decrease in the number of days with headache (from 20 to 10, p = 0.002), pain intensity according to VAS (from 7 to 6, p = 0.01) and VAS sleep (from 6 to 4 points, p = 0.003). In the group without correction of insomnia, the number of days with headaches significantly decreased (from 15 to 12, p = 0.01), changes in the severity of headache according to VAS (from 7.5 to 6, p = 0.13) and sleep quality (from 6 to 7.5, p = 0.38) did not have a statistically significant difference. According to the results of polysomnography, patients who received correction of insomnia had an increase in the duration of slow-wave sleep by 12 minutes (p = 0.02), while in patients from the second subgroup by 4 minutes (p = 0.68).Conclusions. The use of a combination of venlafaxine and doxylamine in the first stages of treatment of patients with chronic tension-type headache and insomnia has an advantage over standard therapy. Combination therapy can reduce the intensity and frequency of headaches and improve sleep quality.
- 23 November 2023
- Published by Remedium, Ltd. in Meditsinskiy sovet = Medical Council
- No. 21,p. 64-69
Open AccessThe effect of insomnia correction on the duration and severity of headaches
Introduction. Chronic tension headache and insomnia are a common mutually aggravating pathology. Drugs used to treat these nosologies most often worsen the course of the concomitant disease.Objective. To evaluate the effect of insomnia correction on the intensity and frequency of headachesMaterials and methods. The study involved 27 patients (25 women, 2 men) with chronic tension-type headache and sleep disorders. The median age was 43 ± 14.8 years. In accordance with the purpose of the study, the clinical group was divided into 2 subgroups. The first group was treated with venlafaxine and doxylamine, the patients of the second group received only venlafaxine treatment. The assessment was carried out before the start of treatment and 8 weeks after, using visual analogue scales for headache, sleep, health status, assessing the severity of insomnia using the Morin scale and the Pittsburgh Sleep Quality Inventory (PSQI), assessing the emotional state using the Sheehan anxiety and Beck depression scales and polysomnography.Results. In subgroup 1, which received correction of insomnia, there was a significant decrease in the number of days with headache (from 20 to 10, p = 0.002), pain intensity according to VAS (from 7 to 6, p = 0.01) and VAS sleep (from 6 to 4 points, p = 0.003). In the group without correction of insomnia, the number of days with headaches significantly decreased (from 15 to 12, p = 0.01), changes in the severity of headache according to VAS (from 7.5 to 6, p = 0.13) and sleep quality (from 6 to 7.5, p = 0.38) did not have a statistically significant difference. According to the results of polysomnography, patients who received correction of insomnia had an increase in the duration of slow-wave sleep by 12 minutes (p = 0.02), while in patients from the second subgroup by 4 minutes (p = 0.68).Conclusions. The use of a combination of venlafaxine and doxylamine in the first stages of treatment of patients with chronic tension-type headache and insomnia has an advantage over standard therapy. Combination therapy can reduce the intensity and frequency of headaches and improve sleep quality.
- Open Access
- 24 March 2023
- Published by Wiley in Pain Research and Management
- Vol. 2023, 1-8
The Effectiveness of Various Types of Electrical Stimulation of the Spinal Cord for Chronic Pain in Patients with Postherpetic Neuralgia: A Literature Review
Introduction. Postherpetic neuralgia (PHN) is a severe condition that remains a challenge to treat. Spinal cord stimulation (SCS) is used in cases of insufficient efficacy of conservative treatment. However, in contrast to many other neuropathic pain syndromes, there is a huge problem in reaching long-term stable pain relief in patients with PHN using conventional tonic SCS. The objective of this article was to present a review of the current management strategies of PHN, their efficacy, and safety. Materials and Methods. We searched for articles containing the keywords spinal cord stimulation AND postherpetic neuralgia, high-frequency stimulation AND postherpetic neuralgia, burst stimulation AND postherpetic neuralgia and dorsal root ganglion stimulation AND postherpetic neuralgia in Pubmed, Web of Science, and Scopus databases. The search was limited to human studies published in the English language. There were no publication period limitations. Bibliographies and references of selected publications on neurostimulation for PHN were further manually screened. The full text of each article was studied once the abstract was analyzed by the searching reviewer and found appropriate. The initial search yielded 115 articles. Initial screening based on abstract and title allowed us to exclude 29 articles (letters, editorials, and conference abstracts). The full-text analysis allowed us to exclude another 74 articles (fundamental research articles, research utilizing animal subjects, and systemic and nonsystemic reviews) and results of PHN treatment presented with other conditions, leaving 12 articles for the final bibliography. Results. 12 articles reporting on the treatment of 134 patients with PHN were analyzed, with a disproportionally large amount of traditional SCS treatment than that to alternative SCS: DRGS (13 patients), burst SCS (1 patient), and high-frequency SCS (2 patients). Long-term pain relief was achieved in 91 patients (67.9). The mean VAS score improvement was 61.4 with a mean follow-up time of 12.85months. Although the number of patients in alternative SCS studies was very limited, almost all of them showed good responses to therapy with more than 50 VAS improvement and reduction of analgesic dosage. The article contains a review analysis of 12 articles concerning the current methods of treatment for postherpetic neuralgia including conservative treatment, spinal cord stimulation, and novel neuromodulation strategies. Available information on the pathophysiology of PHN and the effect or stimulation on its course, together with a number of technical nuances concerning various types of neurostimulation are also elucidated in this article. A number of alternative invasive treatments of PHN are also discussed. Conclusions. Spinal cord stimulation is an established treatment option for patients with pharmacologically resistant PHN. High-frequency stimulation, burst stimulation, and dorsal root ganglion stimulation are promising options in the management of PHN due to the absence of paresthesias which can be painful for patients with PHN. But more research is still required to recommend the widespread use of these new methods.
- 24 March 2023
- Published by Wiley in Pain Research and Management
- Vol. 2023, 1-8
Open AccessThe Effectiveness of Various Types of Electrical Stimulation of the Spinal Cord for Chronic Pain in Patients with Postherpetic Neuralgia: A Literature Review
Introduction. Postherpetic neuralgia (PHN) is a severe condition that remains a challenge to treat. Spinal cord stimulation (SCS) is used in cases of insufficient efficacy of conservative treatment. However, in contrast to many other neuropathic pain syndromes, there is a huge problem in reaching long-term stable pain relief in patients with PHN using conventional tonic SCS. The objective of this article was to present a review of the current management strategies of PHN, their efficacy, and safety. Materials and Methods. We searched for articles containing the keywords spinal cord stimulation AND postherpetic neuralgia, high-frequency stimulation AND postherpetic neuralgia, burst stimulation AND postherpetic neuralgia and dorsal root ganglion stimulation AND postherpetic neuralgia in Pubmed, Web of Science, and Scopus databases. The search was limited to human studies published in the English language. There were no publication period limitations. Bibliographies and references of selected publications on neurostimulation for PHN were further manually screened. The full text of each article was studied once the abstract was analyzed by the searching reviewer and found appropriate. The initial search yielded 115 articles. Initial screening based on abstract and title allowed us to exclude 29 articles (letters, editorials, and conference abstracts). The full-text analysis allowed us to exclude another 74 articles (fundamental research articles, research utilizing animal subjects, and systemic and nonsystemic reviews) and results of PHN treatment presented with other conditions, leaving 12 articles for the final bibliography. Results. 12 articles reporting on the treatment of 134 patients with PHN were analyzed, with a disproportionally large amount of traditional SCS treatment than that to alternative SCS: DRGS (13 patients), burst SCS (1 patient), and high-frequency SCS (2 patients). Long-term pain relief was achieved in 91 patients (67.9). The mean VAS score improvement was 61.4 with a mean follow-up time of 12.85months. Although the number of patients in alternative SCS studies was very limited, almost all of them showed good responses to therapy with more than 50 VAS improvement and reduction of analgesic dosage. The article contains a review analysis of 12 articles concerning the current methods of treatment for postherpetic neuralgia including conservative treatment, spinal cord stimulation, and novel neuromodulation strategies. Available information on the pathophysiology of PHN and the effect or stimulation on its course, together with a number of technical nuances concerning various types of neurostimulation are also elucidated in this article. A number of alternative invasive treatments of PHN are also discussed. Conclusions. Spinal cord stimulation is an established treatment option for patients with pharmacologically resistant PHN. High-frequency stimulation, burst stimulation, and dorsal root ganglion stimulation are promising options in the management of PHN due to the absence of paresthesias which can be painful for patients with PHN. But more research is still required to recommend the widespread use of these new methods.
- 1 January 2022
- Published by Media Sphere Publishing Group in S.S. Korsakov Journal of Neurology and Psychiatry
- Vol. 122 (5) , 42-47
Nightmares in patients with insomnia
Исследования показывают высокую частоту коморбидности инсомнии и ночных кошмаров (НК), которые отягощают и приводят к хронизации друг друга. Механизмы их взаимовлияния различны: инсомния меняет характер сновидений как опосредованно через характерную для нее эмоциональную гиперактивацию, так и вследствие частых пробуждений. Вместе с тем частые повторяющиеся неприятные и устрашающие сновидения могут сами по себе увеличивать частоту ночных пробуждений и ухудшить качество сна. Коморбидность инсомнии и НК должна учитываться при выборе терапевтической тактики у данной категории пациентов. Приоритетными являются препараты, не вызывающие в качестве побочного эффекта НК, а также психотерапия.
- 1 January 2022
- Published by Media Sphere Publishing Group in S.S. Korsakov Journal of Neurology and Psychiatry
- Vol. 122 (5) , 42-47
Nightmares in patients with insomnia
Исследования показывают высокую частоту коморбидности инсомнии и ночных кошмаров (НК), которые отягощают и приводят к хронизации друг друга. Механизмы их взаимовлияния различны: инсомния меняет характер сновидений как опосредованно через характерную для нее эмоциональную гиперактивацию, так и вследствие частых пробуждений. Вместе с тем частые повторяющиеся неприятные и устрашающие сновидения могут сами по себе увеличивать частоту ночных пробуждений и ухудшить качество сна. Коморбидность инсомнии и НК должна учитываться при выборе терапевтической тактики у данной категории пациентов. Приоритетными являются препараты, не вызывающие в качестве побочного эффекта НК, а также психотерапия.
- 1 January 2022
- Published by Media Sphere Publishing Group in S.S. Korsakov Journal of Neurology and Psychiatry
- Vol. 122 (3) , 46-52
Comorbidity of tension headache and insomnia
В обзоре показана взаимосвязь между головной болью напряжения (ГБН) и инсомнией. Рассмотрены патофизиологические и психологические механизмы их взаимного влияния друг на друга. Приведены доказательства того, что сочетание этих патологий зачастую приводит к развитию дезадаптирующих копинг-стратегий, усугубляющих состояние пациента. Подробно рассмотрены особенности и трудности терапии пациентов, страдающих ГБН и инсомнией. Показано, что лечение таких пациентов должно включать подходы, направленные на купирование ГБН, расстройства сна и сопутствующие эмоциональные нарушения с применением лекарственных и нелекарственных методов лечения.
- 1 January 2022
- Published by Media Sphere Publishing Group in S.S. Korsakov Journal of Neurology and Psychiatry
- Vol. 122 (3) , 46-52
Comorbidity of tension headache and insomnia
В обзоре показана взаимосвязь между головной болью напряжения (ГБН) и инсомнией. Рассмотрены патофизиологические и психологические механизмы их взаимного влияния друг на друга. Приведены доказательства того, что сочетание этих патологий зачастую приводит к развитию дезадаптирующих копинг-стратегий, усугубляющих состояние пациента. Подробно рассмотрены особенности и трудности терапии пациентов, страдающих ГБН и инсомнией. Показано, что лечение таких пациентов должно включать подходы, направленные на купирование ГБН, расстройства сна и сопутствующие эмоциональные нарушения с применением лекарственных и нелекарственных методов лечения.
- 1 January 2021
- Published by Media Sphere Publishing Group in Russian Journal of Pain
- Vol. 19 (2)
Efficiency and duration of radiofrequency denervation of facet joints for lower back pain
Боль в спине — одна из ведущих жалоб при обращении к неврологу лиц трудоспособного и пожилого возраста. Спонтанный регресс болевого синдрома в течение 6 нед наблюдается у 50% пациентов. Остальные случаи требуют активного медицинского вмешательства. Несмотря на обилие обезболивающих и нестероидных противовоспалительных препаратов, не всегда удается достичь адекватного купирования боли. Один из самых распространенных источников хронической боли в спине — фасеточный сустав. Наиболее безопасным и эффективным методом лечения является радиочастотная денервация фасеточных суставов. В обзоре представлены современные данные об эффективности и безопасности применения радиочастотной денервации у пациентов с болью в спине, обусловленной поражением фасеточных суставов, а также об изменениях качества жизни таких пациентов.
- 1 January 2021
- Published by Media Sphere Publishing Group in Russian Journal of Pain
- Vol. 19 (2)
Efficiency and duration of radiofrequency denervation of facet joints for lower back pain
Боль в спине — одна из ведущих жалоб при обращении к неврологу лиц трудоспособного и пожилого возраста. Спонтанный регресс болевого синдрома в течение 6 нед наблюдается у 50% пациентов. Остальные случаи требуют активного медицинского вмешательства. Несмотря на обилие обезболивающих и нестероидных противовоспалительных препаратов, не всегда удается достичь адекватного купирования боли. Один из самых распространенных источников хронической боли в спине — фасеточный сустав. Наиболее безопасным и эффективным методом лечения является радиочастотная денервация фасеточных суставов. В обзоре представлены современные данные об эффективности и безопасности применения радиочастотной денервации у пациентов с болью в спине, обусловленной поражением фасеточных суставов, а также об изменениях качества жизни таких пациентов.